Share
The pharma industry briefing
The latest news, approvals and clinical trials you need to know about this month
Data:
News in Numbers
Data: News in Numbers
$300m
Bristol Myers Squibb takes on racial inequality with $300m pledge to up diversity, improve healthcare access.
10%
The number of patients admitted for routine treatment in hospitals in England was down 67% in June compared with the same time last year, NHS figures show.
67%
190 million
AstraZeneca joins other top flu vaccine players Sanofi, GlaxoSmithKline and Seqirus in efforts to boost flu vaccine manufacturing for the 2020-2021 season. Those companies plan to ship a combined 190 million doses.
$37
Moderna has announced plans to charge between $32 to $37 per dose for its mRNA shot, dubbed mRNA-1273, for some “smaller-volume” purchasers.
86
New research from UC Berkeley and the University of Chicago found clear evidence of a drug dose gender gap for 86 different medications approved by the FDA.
Data: News in Numbers
$300m
Bristol Myers Squibb takes on racial inequality with $300M pledge to up diversity, improve healthcare access.
67%
The number of patients admitted for routine treatment in hospitals in England was down 67% in June compared with the same time last year, NHS figures show.
190 million
AstraZeneca joins other top flu vaccine players Sanofi, GlaxoSmithKline and Seqirus in efforts to boost flu vaccine manufacturing for the 2020-2021 season. Those companies plan to ship a combined 190 million doses.
$37
Moderna has announced plans to charge between $32 to $37 per dose for its mRNA shot, dubbed mRNA-1273, for some “smaller-volume” purchasers.
86
New research from UC Berkeley and the University of Chicago found clear evidence of a drug dose gender gap for 86 different medications approved by the FDA.
Study shows how viruses operate and evade the immune system
University of Otago researchers have learnt more about how viruses operate and can evade the immune system and are now using their discovery to help learn more about Covid-19.
Source: News Medical
Russia skips ahead in COVID vaccine race, triggering outcry over unproven 'Sputnik V' shot
As global vaccine players rush to deliver Covid-19 vaccines, Russia shocked the world with news that it had approved a locally developed inoculation. But that approval was based on skimpy data, and experts characterised the move as a risky political stunt.
Source: Fierce Pharma
Italy becomes first country to require pharma to disclose public funding for R&D costs
Amid growing clamor for more transparency from the pharmaceutical industry, Italy has become the first country to require drug makers to disclose data about public funding for any of their medicines during negotiations over pricing and reimbursement.
Source: Stat News
Chiesi’s flagship Fabry drug heads for FDA verdict in early 2021
The FDA has started its review of Israeli biotech Protalix BioTherapeutics and partner Chiesi’s Fabry disease therapy pegunigalsidase alfa, setting up a possible approval by 27 January.
Source: Pharmaphorum
Approvals
Cosentyx®
Novartis Cosentyx® receives EU approval for first-line systemic treatment in paediatric psoriasis.
Source: Pharmafield
Viltepso (viltolarsen)
The US FDA has granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
Source: FDA
Evrysdi (risdiplam)
The US FDA has approved Evrysdi (risdiplam) for treatment of spinal muscular atrophy in adults and children aged two months and older.
Source: Roche
Rozlytrek
Roche’s tumour-agnostic therapy Rozlytrek has been approved in the European Union for people with tumours with the NTRK mutation.
Source: Roche
Go to top
Go to top
Share this article
